European Archives - Page 912 of 1463 - European Medical Journal

Clarity on Cannabinoid-Based Products in Medicine

EMJ Neurology 9 [Supplement 1] 2021

This novel, extensive publication by scientific experts describes the present situation regarding medicinal use…

Talking to Vanessa Pott

Vanessa Pott, Director, Global Patient Insights and Advocacy, Merck KGaA, discusses patient advocacy and supporting carers.

Neph 9.1 Content Image

Review of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) Virtual Congress 2021

BERLIN, the modern architectural capital city of Germany hosted this year’s ERA-EDTA Virtual Congress that took place on 5-8th June 2021.

Neph 9.1 Content Image

EMJ Nephrology 9.1 2021

This issue of EMJ Nephrology includes the latest peer-reviewed research alongside a review of the ERA–EDTA Congress 2021.

Secondary Hyperparathyroidism in Non dialysis Chronic Kidney Disease

Secondary Hyperparathyroidism in Non-dialysis Chronic Kidney Disease

Chronic kidney disease can result in morbidity and mortality not only due to renal dysfunction itself, but also to associated…

Neph 9.1 Content Image

Nephrotoxic Mechanisms of Gadolinium: Implications for the Use of Gadolinium-Based Contrast Agents

Gadolinium-based contrast agents are widely used for MRI. Although they may be considered well-tolerated at recommended dosing levels, recent evidence supports the deposition of free gadolinium in the tissues and its slow release into circulation, resulting in long-term toxicity, which is aggravated in renal patients.

INTERVIEW: KENAR D. JHAVERI

Kenar D. Jhaveri | Professor of Medicine and Associate Chief in the Division of Kidney Diseases and Hypertension, Hofstra/Northwell School of Medicine, Hempstead, New York, USA

‘Sweet Hypoxia’ with Acute Kidney Injury: The Unpredictability of Acute Hypoxic Respiratory Failure in COVID-19 Infection – a Community Hospital Experience

The authors revisited the phenomenon of asymptomatic patients despite very low pulse oximetry readings, the so-called ‘sweet hypoxia’, ‘happy hypoxia’, or ‘silent hypoxaemia’.

Editor’s Pick: Blood Volume Monitoring: A Clinical Tool to Guide Ultrafiltration in Volume Control and Optimisation of Intradialytic Blood Pressure

The use of BVM dates back to the early 1990s when CRIT-LINE® technology (Fresenius Medical Care, Bad Homburg, Germany) was first used as a non-invasive method of measuring haematocrit changes during haemodialysis, in real time, by connection of an additional monitor to the dialysis arterial line set-up.

Neph 9.1 Content Image

Idefirix® (Imlifidase): A Paradigm Shift in Transplanting the Untransplantable?

Imlifidase was granted a conditional marketing authorisation by the European Commission in August 2020 for “desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor.”36 This milestone launched a new era in kidney transplantation for selected patients who would previously have remained untreated.